Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-25-019154
Filing Date
2025-10-24
Accepted
2025-10-23 21:34:42
Documents
19
Period of Report
2025-10-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A formdef14a.htm   iXBRL DEF 14A 895187
2 GRAPHIC def14a_001.jpg GRAPHIC 8984
3 GRAPHIC annexg_001.jpg GRAPHIC 173466
4 GRAPHIC annexg_002.jpg GRAPHIC 283557
  Complete submission text file 0001493152-25-019154.txt   2635523

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE scnx-20241231.xsd EX-101.SCH 4403
6 XBRL DEFINITION FILE scnx-20241231_def.xml EX-101.DEF 7955
7 XBRL LABEL FILE scnx-20241231_lab.xml EX-101.LAB 57644
8 XBRL PRESENTATION FILE scnx-20241231_pre.xml EX-101.PRE 40934
21 EXTRACTED XBRL INSTANCE DOCUMENT formdef14a_htm.xml XML 60290
Mailing Address 20 AUSTIN BLVD. COMMACK NY 11725
Business Address 20 AUSTIN BLVD. COMMACK NY 11725 (800) 261 0281
Scienture Holdings, Inc. (Filer) CIK: 0001382574 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39199 | Film No.: 251414162
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)